Changes in Estrogen Receptor (ER), Progesterone Receptor (PgR) and HER2/neu Status During Primary Systemic Chemotherapy in Breast Cancer

被引：0
|
作者：
Tozuka, K. [1 ]
Horiguchi, J. [1 ]
Takata, D. [1 ]
Rokutanda, N. [1 ]
Nagaoka, R. [1 ]
Tokiniwa, H. [1 ]
Kikuchi, M. [1 ]
Satou, A. [1 ]
Takeyoshi, I. [1 ]
机构：
[1] Gunma Univ Hosp, Maebashi, Gunma, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S126 / S127
页数：2
相关论文
共 50 条
  • [21] Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status
    Fernandez-Morales, Luis A.
    Segui, Miquel A.
    Andreu, Xavier
    Dalmau, Elsa
    Saez, Amparo
    Pericay, Carles
    Santos, Cristina
    Montesinos, Jesus
    Gallardo, Enrique
    Arcusa, Angels
    Saigi, Eugeni
    CLINICAL BREAST CANCER, 2007, 7 (07) : 559 - 564
  • [22] Breast cancer histological grade is associated with estrogen receptor (ER), progesterone receptor (PR), and HER2 expression
    Suzuki, M.
    Kimijima, I.
    Watanabe, K.
    EJC SUPPLEMENTS, 2008, 6 (07): : 102 - 102
  • [23] Histologic and immunophenotypic features of estrogen receptor, progesterone receptor, Her2/neu negative breast carcinomas
    Baruch, AC
    Sneige, N
    Cristofanilli, M
    Resetkova, E
    LABORATORY INVESTIGATION, 2006, 86 : 21A - 21A
  • [24] Histologic and immunophenotypic features of estrogen receptor, progesterone receptor, Her2/neu negative breast carcinomas
    Baruch, AC
    Sneige, N
    Cristofanilli, M
    Resetkova, E
    MODERN PATHOLOGY, 2006, 19 : 21A - 21A
  • [25] Discordance in Estrogen Receptor, Progesterone Receptor and HER2 Status between Breast Primary Cancers and Respective Recurrences
    Budwit, D. A.
    O'Connor, S. M.
    Anders, C. K.
    MODERN PATHOLOGY, 2013, 26 : 32A - 32A
  • [26] Discordance in Estrogen Receptor, Progesterone Receptor and HER2 Status between Breast Primary Cancers and Respective Recurrences
    Budwit, D. A.
    O'Connor, S. M.
    Anders, C. K.
    LABORATORY INVESTIGATION, 2013, 93 : 32A - 32A
  • [27] Estrogen receptor positive operable breast cancer: Does menopausal status impact on HER2 and progesterone receptor status?
    Wang, Ning
    Wang, Bin
    Wang, Yajie
    Hu, Jia
    BREAST, 2011, 20 (06): : 519 - 524
  • [28] Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review
    Yeung, C.
    Hilton, J.
    Clemons, M.
    Mazzarello, S.
    Hutton, B.
    Haggar, F.
    Addison, C. L.
    Kuchuk, I.
    Zhu, X.
    Gelmon, K.
    Arnaout, A.
    CANCER AND METASTASIS REVIEWS, 2016, 35 (03) : 427 - 437
  • [29] Quality and application of oestrogen (ER) and progesterone receptor (PgR) and HER2 analyses
    Viale, Giuseppe
    EJC SUPPLEMENTS, 2007, 5 (05): : 392 - 393
  • [30] The effect of neoadjuvant chemotherapy on hormone receptor status, HER2/neu and prolactin in breast cancer
    Pedrini, Jose Luiz
    Savaris, Ricardo Francalacci
    Schorr, Mario Casales
    Cambruzi, Eduardo
    Grudzinski, Melina
    Zettler, Claudio Galleano
    TUMORI JOURNAL, 2011, 97 (06): : 704 - 710
12345